6533b824fe1ef96bd128087f
RESEARCH PRODUCT
Toll-like Receptor 2 and 4 in Cancer Immunotherapy: Is Nitric Oxide a Mediator?
Cedric SeignezAmandine MartinAli BettaiebJean-françois JeanninCatherine Paulsubject
Toll-like receptorbusiness.industrymedicine.medical_treatmentBiochemistryNitric oxidechemistry.chemical_compoundMediatorchemistryCancer immunotherapyImmunologyGeneticsCancer researchMolecular MedicineMedicinebusinessBiotechnologyyear | journal | country | edition | language |
---|---|---|---|---|
2010-01-01 | Forum on Immunopathological Diseases and Therapeutics |